A Year In Review
The ADC space is expanding faster than ever, with a 33% surge in new drugs and 23% in new clinical trials. Breakthroughs in bispecific ADCs and dual-payload technologies are shaping the future, while $64.3 billion in deals signal strong industry confidence.
Our Landscape Review delivers the key insights you need to stay competitive—from clinical trends to investment opportunities. Download now to make smarter, strategic decisions in this rapidly evolving field.
Download Now
Lead the future of ADC innovation!
The Beacon ADC 2024 Landscape Review is your definitive guide to the latest advancements in antibody-drug conjugates. Explore novel payloads, targets, and key clinical and commercial trends. Download your copy and stay competitive.
Part 1: The Drug & Trial Landscape
Part 2: The Commercial Landscape & Future of ADCs
Part 3: Insights & Trends from Hanson Wade Intelligence
Report Contents
The Drug Landscape
A deep dive into the ADC assets added to Beacon in 2024, highlighting growth trends, emerging modalities, and key therapeutic targets.
The Trial Landscape
Analysis of the 660 new ADC trials, including phase distribution, success rates, and trial discontinuation insights.
The Commercial Landscape
A review of the 99 ADC deals in 2024, analyzing investment trends, partnerships, and market shifts.
The Future of ADCs
Emerging trends in ADC drug development, from novel payload mechanisms to expanding clinical applications.
Regulatory Announcements
Key ADC approvals and regulatory developments shaping the industry’s evolving compliance landscape.
You May Also Be Interested In...
Bispecific: 2024 Landscape Review
ADC: 2024 Landscape Review
ADCs in the Oncology Landscape Infographic
Beacon ADC: ASH 2024 Post-Conference Report
Strategic Insights for Biopharma Innovation Report
H1 2024 Bispecific Landscape Review
Find Out More
Beacon is the essential decision-support tool for developers of complex therapeutics. Our market-defining, proprietary ontologies combined with the most accurate and comprehensive life sciences data, provide our customers with unparalleled visibility of the drug, trial and commercial landscape. Each dataset features proprietary, hyper-relevant search and filtering tailored to specific modalities, in-depth data, plus additional market insight curated by our subject matter experts.
With Beacon, you can make drug development decisions with confidence. This is why 23 out of the world’s top 25 drug developers trust us.
Any questions? Get in touch
Our dedicated account and research teams can help you with questions by showing you how this insight and data is collated on Beacon.
